Significant Accounting Policies - Schedule of Concentrations of Risk Percentage (Details) - Customer Concentration Risk	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Customer A | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage					15.80%
Customer B | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage				13.00%
Customer B | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage					19.50%
Customer C | Accounts Receivable, Net
Significant Accounting Policies [Line Items]
Concentration risk, percentage			10.10%
Genentech, Inc. and Roche Group | Revenue
Significant Accounting Policies [Line Items]
Concentration risk, percentage	23.20%	45.10%	30.00%	38.20%